Jennifer E. Cook
Director · 6 filings · Latest: Aug 31, 2026
BridgeBio Pharma, Inc.
Denali Therapeutics Inc.
Jazz Pharmaceuticals plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JAZZ | Cook Jennifer E. | — | Aug 31, 2026 | Proposed Sale | $244.54 | 3,507 | $857.6K | — | |
BBIO | Jennifer E. Cook | Director | Jul 9, 2026 | Sale | $88.54 | 148,589 | $13.2M | 8,383 | |
BBIO | Jennifer E. Cook | Director | Jul 9, 2026 | Option Exercise | $24.96 | 148,589 | $3.7M | 156,972 | |
BBIO | JENNIFER COOK | — | Jul 9, 2026 | Proposed Sale | $88.54 | 148,589 | $13.2M | — | |
BBIO | Jennifer E. Cook | Director | Jun 24, 2026 | Sale | $70.00 | 37,167 | $2.6M | 8,383 | |
BBIO | Jennifer E. Cook | Director | Jun 24, 2026 | Option Exercise | $12.28 | 37,167 | $456.5K | 45,550 | |
BBIO | Jennifer E. Cook | Director | Jun 23, 2026 | Sale | $68.57 | 2,196 | $150.6K | 8,383 | |
BBIO | JENNIFER COOK | — | Jun 24, 2026 | Proposed Sale | $70.00 | 37,167 | $2.6M | — | |
BBIO | JENNIFER COOK | — | Jun 23, 2026 | Proposed Sale | $68.57 | 2,196 | $150.6K | — | |
BBIO | Jennifer E. Cook | Director | Jun 15, 2026 | Sale | $66.62 | 90,240 | $6.0M | 6,589 | |
BBIO | Jennifer E. Cook | Director | Jun 15, 2026 | Option Exercise | $10.16 | 83,088 | $844.6K | 96,829 | |
BBIO | JENNIFER COOK | — | Jun 15, 2026 | Proposed Sale | $66.62 | 90,240 | $6.0M | — | |
JAZZ | Cook Jennifer E. | — | Aug 8, 2025 | Proposed Sale | $112.00 | 3,731 | $417.9K | — |